Abstract-Various novel 10-alkyl-2-deoxo-2-methylthioflavin-5-oxides and their 2-alkylamino derivatives were prepared by facile nitrosative cyclization of 6-(N-alkylanilino)-2-methylthiopyrimidin-4(3H)-ones followed by nucleophilic replacement of the 2-methylthio moiety by different amines, and acidic hydrolysis of the 2-methylthio moiety afforded the corresponding flavin derivatives. 2-Deoxo-2-methylthio-5-deazaalloxazines and 2-deoxo-2-methylthioalloxazine-5-oxides were also prepared by Vilsmeier reaction and by nitrosation of 6-anilino-2-methylthiopyrimidin-4(3H)-ones, respectively. Then, they were subjected to nuceleophilic replacement with appropriate amines to produce the corresponding 2-alkylamino derivatives. Regiospecific N 3 -alkylation of 2-deoxo-2-methylthioalloxazine-5-oxides was carried out with various alkylating agents in the usual way. The antitumor activities against CCRF-HSB-2 and KB tumor cells have been investigated in vitro, and many compounds showed promising antitumor activities. Furthermore, AutoDock molecular docking into PTK (PDB: 1t46) has been done for lead optimization of the aforementioned compounds as potential PTK inhibitors.
2-alkylamino-2-deoxo-5-deazaflavins (8a,b) by heating with Vilsmeier reagent at 90 °C for three hours, and for the preparation of 2-alkylamino-2-deoxoflavin-5-oxides (9a,b) by nitrosative cyclization involving excess NaNO 2 in glacial acetic acid for 2-3 hours.
Based on our previous structure based drug design (SBDD) study and docking investigation of different flavin analogs, and aiming to discovery of antitumor agents, 22 it was concluded from the results considering SAR that the higher binding affinities were obtained with the structure features on the flavin or 5-deazaflavin skeleton; NH 2 or Ph group at the C 2 -position, H (or alloxazine conformation) or Ph group at the N 10 -position. Herein, we tried to synthesize the designed analogs based on AutoDock possessing higher binding affinities, namely, 2-deoxo-2-methylthio-5-deazaalloxazines (12) and 2-deoxo-2-methylthioalloxazine-5-oxides (13) . These derivatives can be synthesized from the key intermediate, 6-anilino-2-methylthiopyrimidin-4(3H)-ones (11) , by facile methods of interactions (Scheme 4). The requisite key compounds 11a-e can not be prepared directly from 6-chloro-2-methylthiopyrimidin-4(3H)-ones by adapting the same procedure for the preparation of 6-(N-alkylanilino)-2-methylthiopyrimidin-4(3H)-ones (1a-j). 18 Both of the 6-chloro and 2-methylthio groups were replaced by the anilines. Therefore, the compounds 11a-e were prepared in two steps reaction. The first reaction by amine exchange route, namely, the reaction of 6-amino-2-thiouracil with anilines in the presence of their corresponding anilinium chloride salts at high temperature to afford the corresponding 6-anilino-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidins (10a-e) in 67-83% yields. Compounds 10a-e were prepared by modification of known procedure 23, 24 to improve the yields and to get more pure products. Hence, compound 10a was obtained in higher yield of 83%
(literatures 23, 24 : 78% and 68% yields). In our proposed procedure, the anilinium chloride derivatives were used in more quantities of 1.5-2.0 equivalents and the crude product was further purified by dissolving it in alkaline solution, then reprecipitation by 10% HCl to get more pure compounds. The second step reaction involves S-methylation by MeI in alkaline solution in ice bath to afford the 2-methylthio analogs (11a-e) in excellent yields of 77-98%. Synthesis of 2-thio-5-deazaalloxazines and 2-thioalloxazine-5-oxides were not successful directly from the compounds 10a-e. This may be attributed to oxidative dimerization of the 2-thioxo derivatives. Therefore, the 2-thioxo moiety should be protected by methylation before the cyclization step to get the desired compounds 12 and 13. The 2-deoxo-2-methylthio-5-deazaalloxazines (12a,b) were prepared from 11 by Vilsmeier reagent at 90 °C for 1 h to afford the compounds 12a,b as yellow needles in 72 and 63% yields, respectively. 2-Deoxo-2-methylthioalloxazine-5-oxides (13a-e) were also prepared from 11 by nitrosative cyclization using excess NaNO 2 in glacial acetic acid at 10-15 °C and then at room temperature for 1-2 h. After adding NaNO 2 to the cold reaction mixture, the formed greenish yellow nitroso intermediates have to be dissolved in acetic acid by mild warming in water bath to enhance the prompt cyclization to afford the red products in 66-89% yields (Scheme 4). Moreover, the nucleophilic replacement of 2-methylthio group for these compounds 12 and 13 by alkylamines was carried out by heating the reaction mixture with appropriate amines in DMF or n-butanol under reflux for high boiling point amines (morpholine or N-hydroxyethyl-N-methylamine) for 6-24 hours or in sealing vessel for volatile one (dimethylamine) for 8 hours to afford the corresponding yellow crystalline solid of the 2-alkylamino analogs (14a,b
and 15a,b) in 67-86% yields. This replacement was accompanied by deoxygenation of 2-deoxo-2-methylthioalloxazin-5-oxides (13) to produce the 2-alkylamino-2-deoxoalloxazine analogs (15a,b). Interestingly, the regiospecific N 3 -alkylation of 13a-e was carried out using excess alkyl iodide or bromide in the presence of anhydrous potassium carbonate in DMF at room temperature to afford the 3-alkyl-2-deoxo-2-methylthioalloxazine-5-oxides (16a-e) in 71-82% yields. This alkylation is 100% regioselective at the N 3 -position, giving highly pure one spot product without purification by column chromatography as previously described in methylation of 2-deoxo-2-phenyl-5-deazaflavins. 6 The discrimination between the positional isomers, 3-methyl-2-deoxo-2-methylthioalloxazine-5-oxide (16a) and 10-methyl-2-deoxo-2-methylthioflavin-5-oxide (2a), was accurately proved by obvious different melting points and IR spectra where the 4-oxo group of 3-methyl analog (16a) was shown at higher frequency of 1700 cm -1 , whereas that of 10-methyl analog (2a) was shown at lower frequencies 1645 cm -1 . In 1 H NMR spectra, the N 3 -methyl of 16a as a singlet signal was shown at 3.64 ppm, while (tautomers). Especially, such duplicated spectra were observed in the range of 4.0-9.0 ppm based on the tautomers of the guanidine adjacent to the carbonyl group. At higher temperature of 85-100 °C, the coalescence of the duplicated spectrum was observed to produce the single spectrum. This phenomenon is mainly attributed to the presence of a secondary amine at the 2-position, whereas it does not take place in case of 2-substituted primary and
In vitro antitumor activities of different 2-methylthioflavin-5-oxides, alloxazin-5-oxides,

5-deazaalloxazines, and their 2-alkylamino derivatives against human tumor cell lines
The compounds (2, 4, 6, 8, 9, 12, 13, 15, and 16) synthesized in this study were tested in vitro for their growth inhibitory activities against two human cultured tumor cell lines, namely, human T-cell acute lymphoblastoid leukemia cell line (CCRF-HSB-2) and human oral epidermoid carcinoma cell line (KB) by using the modified MTT colorimetric assay. 25 The antitumor agent, cytosine arabinoside (Ara-C) was used as a positive control in this study.
As can be noticed in Table 1 , some compounds of 2-deoxo-2-methylthioflavin-5-oxides (2), 2-deoxo-2-alkylaminoflavin-5-oxides (4), flavin-5-oxides (6), and 2-deoxo-2-alkylamino-5-deazaflavins (8) have been found to show significant antitumor activities, but they were of inferior antitumor activities than that of Ara-C against In comparison with the antitumor activities of the above studied flavin-5-oxide, 2-alkylaminoflavin-5-oxide, and 5-deazaflavin derivatives (2, 4, 5, and 8), which revealed the IC 50 in the range of 1.46-2.7 and 0.61-2.1 µg/mL against CCRF-HSB-2 and KB tumor cell lines, respectively, and the activities of our previously reported potent 2-deoxo-2-phenylflavin analogs, 6 which revealed the IC 50 in the range of 0.15-0.68 µg/mL for CCRF-HSB-2 cells and 0.16-0.72 µg/mL for KB cells. It can be explained that the phenyl group at the C 2 -position provides better affinity to the PTK enzyme on account of the force of electrostatic attraction between the planar phenyl and the target site pocket of the PTK. Hence, the phenyl derivatives exhibit a good fitting into the active site and better antitumor activity. The results considering SAR revealed that the highest antitumor activities (ca. 1.5 µg/mL) were obtained with the structure features on the flavin-5-oxide, 5-deazaflavin, and alloxazine skeletons; SMe or HNMe group at the C 2 -position, H (or alloxazine conformation) or Me group at the N 10 -position, and unsubstituted quinoxaline nucleus or substituted by 7-Me, or 9-Me group. The SAR revealing moderate antitumor activity (ca. 5.5 µg/mL) was obtained with the structure features: HN-n-Bu or oxo at the C 2 -position, Me or Et group at the N 10 -position, and unsubstituted quinoxaline nucleus or substituted by 7-OMe group. Noteworthy, the N 3 -alkyl substituted alloxazin-5-oxides exhibited lower antitumor activities than their unsubstituted analogs as shown in Table 1 . And the N-5-oxide analogs revealed higher potencies than those of 5-deazaflavins. These results confirm our previously reported SAR study. 
Molecular docking study
Due to their involvement in various forms of cancers, PTKs have become prominent targets for therapeutic intervention. The selective PTK inhibitors into the receptor and non-receptor PTK represent a promising class of exactly superimposed on the native co-crystallized one with RMSD being 0.25 and binding free energies (ΔG b ) of -18.43 kcal/mol. The hydrogen bonds exhibited between the docked ligand and amino acids were quite same to them between the native ligand and amino acids.
AutoDock binding affinities of the synthesized and the designed compounds into PTK
The binding affinity was evaluated by the binding free energies (ΔG b , kcal/mol), inhibition constants (K i ), hydrogen bonds, and RMSD values. The compounds, which revealed the highest binding affinities (in other words, lowest binding free energies) within PTK and the hydrogen bond interactions into the target macromolecule, are represented in Table 2 . These compounds include 2-dimethylamino-2-deoxoalloxazine (3), 10-alkyl-2-alkylamino-2-deoxoflavin-5-oxides (4b-e), 2-alkylamino-10-methyl-5-deazaflavins (8a,b), 2-alkylamino-2-deoxo-10-methyl-5-oxide (16b). Compounds 2-(2-hydroxyethylamino)-7,10-dimethyl-2-deoxoflavin-5-oxide (4e) and 10-methyl-2-methylamino-2-deoxoflavin-5-oxide (9a) as shown in Figure 2 Figure 5 .
Whereas, the growth inhibition against KB tumor cells revealed a reasonable correlation with Autodock binding free energies for compounds 2e,f,g, 4b,e, 8b, 9a, 13b, and 16b,c,e of correlation coefficient (R 2 ) of 0.68 as shown in Figure 6 .
Conclusions
In this study, various novel 10-alkyl-2-deoxo-2-methylthioflavin-5-oxides (2a-i) were synthesized from 6-(N-alkylanilino)-2-methylthiopyrimidin-4(3H)-ones (1a-i) by nitrosative cyclization. The 2-alkylamino derivatives (4a-e) were synthesized by the facile replacement of the C 2 -methylthio moiety of 2 by different amines.
Flavins (5a,b) and flavin-5-oxide (6) were prepared by acidic hydrolysis of 2 in excellent yields. Nucleophilic substitution of 2-methylthio group of the non-cyclized 6-(N-methylanilino)-2-methylthiopyrimidin-4(3H)-one (1a)
by an appropriate amine was carried out, followed by Vilsmeier reaction to afford the 2-alkylamino-2-deoxo- 
Experimental
Chemistry
Mps were obtained on a Yanagimoto micro melting point apparatus and were uncorrected. Microanalyses were measured by Yanaco CHN Corder MT-5 apparatus. IR spectra were recorded on a JASCO FT/IR-200 spectro-photometer as Nujol mulls. 1 H NMR spectra were obtained using a Varian VXR 300 MHz spectrophotometer and chemical shift values were expressed in δ values (ppm) relative to tetramethylsilane (TMS) as internal standard.
Coupling constants are given in Hz. All NH and OH protons were exchangeable with D 2 O. UV spectra were measured in absolute EtOH using Beckman DU-68S UV spectrophotometer and absorption values followed by sh refer to wave lengths at which shoulders or inflexions occur in the absorption. All reagents were of commercial quality and were used without further purification. Organic solvents were dried in the presence of an appropriate drying agent and were stored over suitable molecular sieves. Reaction progress was monitored by analytical thin layer chromatography (TLC) on pre-coated glass plates (silica gel 60F 254 -plate-Merck) and the products were visualized by UV light. 
General
10-Ethyl-2-methylthio-4-oxo-4,10-dihydrobenzo[g]pteridine-5-oxide (2b
7-Chloro-10-methyl-2-methylthio-4-oxo-4,10-dihydrobenzo[g]pteridine-5-oxide (2g
Preparation of 2-deoxo-2-dimethylaminoalloxazine {2-dimethylamino-4-oxo-3,4-dihydrobenzo[g]-pteridine} (3).
A mixture of 2-deoxo-10-methyl-2-methylthioflavin-5-oxide (2a, 1.4 g, 5.0 mmol) and 50% aqueous dimethylamine (50 mL) was heated in steel sealed tube at 160-165 °C (15 kg/cm 2 pressure) for 4 h. After the reaction was complete, the precipitated crystals were collected by filteration, and mother liquor was evaporated in vacuo to get the second crop. The product was washed with water, dried and recrystallized from EtOH to afford the yellow crystals in 89% yield. cooled under refrigeration overnight, the resulting yellow crystals were collected by filtration to get the first crop.
The filtrate was concentrated in vacuo and the residue was treated with ethanol or water to get the second crop free from amines. The collected solids were dried and recrystallized from an appropriate solvent to give the corresponding products as bright yellow-orange needles in 62-89% yields. hydrochloric acid (250 mL). Then, the mixture was refluxed for 7-12 hours, and the resulting clear yellow solution was concentrated in vacuo. The yellow residue was treated with water and neutralized with aqueous ammonia (pH 7). The precipitate powdery crystals were filtered off, washed well with water, dried and recrystallized from acetic acid to afford the corresponding products as yellow needles in 68-97% yields. 
7-Methoxy-10-methyl-2-piperidino-4-oxo-4,10-dihydrobenzo[g]pteridine-5-oxide (4a
6-H), 7.95 (1H, br d, J 8,9 = 9.0 Hz, 8-H); Anal. calcd for C 18 H 21 N 5 O 2 : C, 63.70; H, 6.24; N, 20.64. Found: C, 63.99
7-Methoxy-10-methyl-2,4-dioxo-2,3,4,10-tetrahydrobenzo[g]pteridine-5-oxide (6).
Preparation of 2-methylamino-6-(N-methylanilino)pyrimidin-4(3H)-one (7a).
A mixture of 6-(N-methylanilino)-2-methylthiopyrimidin-4(3H)-one (1a, 0.5 g, 2.0 mmol) and 40% aqueous methylamine (50 mL) in steel sealed tube was heated at 160 °C (10 kg/cm 2 pressure) for 15 h. After the reaction was complete, the resulting clear yellow solution was concentrated in vacuo. The yellow residue was treated with ethyl acetate to get the solid, which was filtered off, washed with water, dried and crystallized from DMF to afford the pure product as colorless needles. 
Preparation of 6-(N-methylanilino)-2-n-octylaminopyrimidin-4(3H)-one (7b).
A mixture of 6-(N-methylanilino)-2-methylthiopyrimidin-4(3H)-one (1a, 1.24 g, 5.0 mmol) and n-octylamine (2.58 g, 0.02 mol) was heated at 160 °C for 10 h. After cooling, the resulting mixture was triturated with water and acidified with acetic acid to remove the excess n-octylamine as salt. The product was extracted from the mixture with dichloromethane (3 x 50 mL) and the extract was washed with saturated brine (2 x 20 mL). The combined organic extracts were dried over anhydrous magnesium sulfate, filtered, and the solvent was removed under reduced pressure to afford the product 7b as orange oil. The product which was dried under vacuum was used for the next step without further purification. 
General procedure for the preparation of 2-alkylamino-2-deoxo-10-methyl-5-deazaflavins {2-alkylamino-10-methylpyrimido[4,5-b]quinolin-4(10H)-ones} (8a,b). A mixture of 2-alkylamino-6-(N-methylanilino)-
pyrimidin-4(3H)-ones (7, 5.0 mmol) and phosphoryl chloride (3.83 g, 25 mmol) in anhydrous DMF (5 mL) was heated under stirring at 90 °C for 3 h. Then, the reaction mixture was poured onto ice and treated with aqueous ammonia (pH 8). The separated yellow crystals were filtered off, washed with water, dried and recrystallized from an appropriate solvent to afford the products as yellow needles in 60-82% yields. 6-(N-anilino)-4-oxo-2-thioxo-1,2,3,4-tetradropyrimidines   (10a-e) . A mixture of 6-amino-2-thiouracil (7.10 g, 0.05 mol), an appropriate aniline (0.1 mol) together with anilinium chloride (0.075-0.10 mol) was heated at 170 °C for 4-12 h. The cooled mixture was diluted with 65% ethanol (200 mL) to afford the solid product, which was collected by filtration, dissolved in hot ca. 5% NaOH solution, and reprecipitated by neutralization with 10% HCl to get more pure product. The solid deposited was collected by suction filtration, washed with water, dried and crystallized from a mixture of DMF and H 2 O to afford the corresponding products as colorless needles in 67-83% yields. Anilino-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine (10a) 
10-Methyl-2-methylaminopyrimido[4,5-b]quinolin-4-(10H)-one (8a
10-Methyl-2-methylamino-4-oxo-4,10-dihydrobenzo[g]pteridine-5-oxide (9a
6-
6-(4-Methoxyanilino)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine (10d
s, 6-NH ), 9.55 (1H, s, OH), 11.51 (1H, br s, 1-NH), 11.81 (1H, br s, 3-NH); Anal. calcd for C 10 H
General procedure for the preparation of 6-anilino-2-methylthio-4-oxo-3,4-dihyropyrimidines (11a-e).
To a solution of 6-anilino-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidines (10, 0.01 mol), in 2N KOH (250 mL) at 0-5 °C was added methyl iodide (2.84 g, 0.02 mol) and the solution was shaken vigorously under chilling for 30 min. The solid precipitated was collected by filtration and the filtrate was neutralized with 10% HCl to get the second crop. The collected solid products were dissolved in hot ca. 5% NaOH solution and reprecipitated by neutralization with 10% HCl to get the more pure products. The solid products were collected by suction filtration and washed with water, dried, crystallized from an appropriate solvent to afford the corresponding silver colored crystals in 77-98% yields. Hydroxyanilino)-2-methylthio-4-oxo-3,4-dihydropyrimidine (11e). Yield, (2.34 g, 94%) ; mp -4(3H)-ones} (12a, b) . A mixture of 6-anilino-2-methylthio-4-oxo-3,4-dihydropyrimidines (11, 0.01 mol) and phosphoryl chloride (7.7 g, 0.05 mol) in anhydrous DMF (10 mL) was heated under stirring at 90 °C for 1 h. Then, the reaction mixture was poured onto ice and neutralized with aqueous ammonia (pH 7). The yellow crystals separated were filtered off, washed with water, dried and recrystallized from an appropriate solvent to afford the corresponding products as pale yellow needles in 63-72% yields. by portions, and the mixture was stirred at room temperature with occasional warming in water bath to enhance the cyclization for 1-2 h. The solid deposited was collected by suction filtration and washed with water. The filtrate was concentrated in vacuo and the residue was diluted with excess water or neutralized with aqueous ammonia (pH 7) to afford the second crop. The solid dried was crystallized from a mixture of DMF and water to afford the corresponding products as yellow or orange needles in 66-89% yields. were dried and recrystallized from ethanol to give the pure products as yellow needles in 82-84% yields. g, 0.10 mol) in DMF (30 mL) was refluxed with stirring for 6 h. After the resulting solution was kept in refrigerator overnight, the yellow crystals precipitated were collected by filtration to get the product which was washed with ethyl acetate, dried and recrystallized from DMF to give the yellow pure product 15a. 
6-Anilino-2-methylthio-4-oxo-3,4-dihydropyrimidine (11a
6-(4-Methylanilino)-2-methylthio-4-oxo-3,4-dihydropyrimidine (11b)
.
6-(4-
2-Methylthiopyrimido[4,5-b]quinolin-4(3H)-one (12a
2-Methylthio-4-oxo-3,4-dihydrobenzo[g]pteridine-5-oxide (13a
2-Morpholinopyrimido[4,5-b]quinolin-4-(3H)-one (14a
Growth inhibitory activities of against human tumor cell lines
The procedure was carried out using the modified 3-(3,4-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay 25 to determine the inhibitory effects of test compounds, namely, 10-alkyl-2-deoxo-2-methylthioflavin-5-oxides (2a-i), 10-alkyl-2-alkylamino-2-deoxoflavin-5-oxides (4a-e), 10-alkylflavins (5a,b), 7-methoxy-10-methylflavin-5-oxide (6), 2-alkylamino-2-deoxo-10-methyl-5-deazaflavins (8a,b), 2-deoxo-10-methyl-2-methylaminoflavin-5-oxide (9a), 2-deoxo-2-methylthio-5-deazaalloxazine (12a), 2-deoxo-2-methylthioalloxazine-5-oxides (13a-d), 2-alkylamino-2-deoxoalloxazines (15a,b), and 3-alkyl-2-deoxo-2-methylthioalloxazine-5-oxides (16a-e), on cell growth in vitro as mentioned in detail in our previous paper. 6 Two human tumor cell lines of CCRF-HSB-2 (human T-cell acute lymphoblastoid leukemia) and KB (human oral epidermoid carcinoma) were used in this study. AraC was used as a positive control, where the IC 50
was determined from the dose-response curve.
Molecular docking study
The automated docking studies were carried out using AutoDock version 3.0.5. 26 First, AutoGrid component of the program pre-calculates a three-dimensional grid of interaction energies based on the macromolecular target using the AMBER force field. The cubic grid box of 80 Å size (x, y, z) with a spacing of 0.375 Å and grid maps were created representing the catalytic active target site region where the native ligand were embedded. Then automated docking studies were carried out to evaluate the binding free energy of the inhibitors within the macromolecules. The GA-LS search algorithm (Genetic algorithm with local search) was chosen to search for the best conformers. The parameters were set using the software ADT (Autodock Tool Kit) on PC which is associated with Autodock 3.0.5. For all docking parameters, default values were used with 10 independent docking runs for each docking case. The
AutoDock performs the task of the docking, where the ligand moves randomly in any one of six degrees of freedom, and the energy of the new ligand ''state'' is calculated. If the energy of the new state is lower than that of the old state, the new one is automatically accepted as the next step in docking.
Preparation of ligands and target protein tyrosine kinase
The compounds involved in this study as ligands include 10-alkyl-2-deoxo-2-methylthioflavin-5-oxides (2), 2-dimethylaminoalloxazine (3), 10-alkyl-2-alkylamino-2-deoxoflavin-5-oxides (4), 10-alkylflavins (5),
7-methoxy-10-methylflavin-5-oxide (6), 2-alkylamino-2-deoxo-10-methyl-5-deazaflavins (8 were removed from the protein and the polar hydrogens and the Kollman-united charges were added to the proteins.
The amino acids of the ligand-target binding site were defined using data in pdbsum http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/ accessed on June 10, 2006.
Molecular modeling and analysis of the docked results
The predicted binding free energy that includes the intermolecular energy and torsional free energy was used as the criterion for ranking. Furthermore, the intermolecular hydrogen bonds, whose effect has already been counted in the binding energy, were also investigated in order to find useful information for drug design. A comparison of the results suggests that the binding free energy is more reliable as a criterion for the virtual screening via molecular docking. Cluster analysis was performed on the docked results using a root mean square (RMS) tolerance of 0.5 Å.
Each of the clusters that exhibited significant negative interaction energies was examined by Accelrys, DS modeling Regarding the hydrogen bond interaction, the more linear hydrogen bond is likely to be more stronger. 29 Therefore, in our modeling results we consider the hydrogen bond angle within about 120° to be of a reasonable strength.
